Skip to content
Back to ACHV

Achieve Life Sciences, Inc.

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
1
Purchases
0
Sales
1
Purchase value
$0.00
Sale value
$175.18K

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Richard Alistair StewartDirector
4
Filed Aug 21, 2026Period of report Aug 19, 20260001193125-26-361182
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 19, 2026
Common StockF120,626$8.493$175.18K208,249Direct
Filing footnotes · 2
  1. F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.4536 to $8.52 per share, inclusive. The reporting person hereby undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. F2The reporting holder is the principal owner of Ricanto Limited.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.